Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis - report from ESC2024

Professor Pardeep Jhund explains that mineralocorticoid receptor antagonists reduced the risk of cardiovascular death or heart failure hospitalization in patients with HF and reduced ejection fraction and also in those with mildly reduced or preserved ejection fraction, according to late-breaking research presented in a Hot Line session at ESC Congress 2024. Video: https://medicaldigest.org/scientific-contents/interview:mineralocorticoid-receptor-antagonists-heart-failure-individual-patient-level-meta-analysis